Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Brandsma (Southampton, United Kingdom). Lipidomic phenotyping of severe asthma. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

Member's Comments

No comment yet.

Related content which might interest you: Ykl-40 and phenotyping of severe asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 Metabolic profiling of severe asthma: implications for phenotyping and treatment Source: ERS Lung Science Conference 2020 Year: 2020 Transcriptome profiling of platelets from patients with severe asthma. Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Phenotypes and endotypes of severe asthma Source: Annual Congress 2012 - PG14 From phenotypes to endotypes of asthma and COPD Year: 2012 Comparative analysis of allergic and non-allergic severe persistent asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Integrating fingerprints: molecular phenotyping of severe asthma Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Diagnostic approach to and phenotyping of severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations. Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Proteomic analysis of T-lymphocytes in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations Source: ERJ Open Res, 7 (3) 00198-2021; 10.1183/23120541.00198-2021 Year: 2021 Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Analysis of phenotypes in a group of severe asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 The need for asthma phenotyping Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018